NCOA2 and hepatocellular carcinoma: In contrast, we previously showed that low expression of SRC-2 in tumors is strongly associated with poor survival in HCC patients [13, 56] and HCC patients harboring SRC-2 missense mutations similarly exhibit poorer overall survival (S12 Fig).